Literature DB >> 8629824

Longitudinal melanonychia in children. A study of eight cases.

C Léauté-Labrèze1, P Bioulac-Sage, A Taïeb.   

Abstract

BACKGROUND AND
DESIGN: Longitudinal melanonychia is rare in white children and represents a difficult clinical challenge. Because of the fear of malignant melanoma, a surgical excision is usually performed, sometimes with definitive aesthetic and functional consequences. Eight children with longitudinal melanonychia who were between the ages of 2 and 14 years underwent follow-up. Surgical excision was performed in five cases. For three children, a wait-and-see policy was adopted, because their longitudinal melanonychia had been unchanged for years at the time of their examination.
RESULTS: Melanoma was never observed in our cases (follow-up, 5.5 years). Histologic examinations performed in five cases showed junctional nevi of the nail matrix, often with dysplasia as commonly seen in juvenile nevi. Two children had postoperative nail dystrophy.
CONCLUSION: In white children, longitudinal melanonychia rarely disappears. Since an ungual melanocytic band can appear at the age when other nevi appear, surgical excision should not be undertaken on different grounds than for other congenital or acquired nevi in children.

Entities:  

Mesh:

Year:  1996        PMID: 8629824     DOI: 10.1001/archderm.1996.03890260069010

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  4 in total

1.  Melanonychia striata with multiple toenail involvement in a child.

Authors:  Alexander K C Leung; Tom Y Woo
Journal:  J Natl Med Assoc       Date:  2004-09       Impact factor: 1.798

2.  Advanced nail surgery.

Authors:  Eckart Haneke
Journal:  J Cutan Aesthet Surg       Date:  2011-09

3.  Melanonychia.

Authors:  Julie Jefferson; Phoebe Rich
Journal:  Dermatol Res Pract       Date:  2012-06-27

4.  Childhood longitudinal melanonychia: case series from Poland.

Authors:  Michał Sobjanek; Martyna Sławińska; Alicja Romaszkiewicz; Wojciech Biernat; Rafał Pęksa; Roman J Nowicki
Journal:  Postepy Dermatol Alergol       Date:  2019-09-10       Impact factor: 1.837

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.